Latest Insights & Developments

Discover how AI solutions from Vamstar can help pharmaceutical companies like Bristol Myers Squibb offset revenue losses due to loss of exclusivity (LoE). This article explores how Vamstar’s predictive market analytics, intelligent procurement tools, and portfolio optimization capabilities empower pharma firms to sustain growth, enhance strategic decisions, and remain competitive against generics. Learn how integrating AI tools can transform LoE challenges into opportunities for innovation and market expansion, as demonstrated by Bristol Myers Squibb’s proactive market strategies

Discover how AI is revolutionising the generics pharmaceutical industry with advanced pricing strategies. Vamstar's AI-driven Pricing Co-Pilot is setting new standards, transforming how companies approach tender pricing and bidding. Learn about the tangible benefits of integrating AI into your pricing processes, including improved accuracy, increased efficiency, and enhanced profitability. Embrace the future of pharma with AI-powered solutions that promise to refine decision-making and boost competitive advantage.

Designed for individuals with Type 2 diabetes who do not use insulin and those with prediabetes, Stelo offers affordable, real-time glucose monitoring without the need for a prescription. Priced at $89 per month, Stelo's introduction intensifies competition in the CGM market, challenging existing players like Abbott. This move not only expands Dexcom's market reach but also drives innovation in health monitoring, making advanced diabetes management more accessible to millions.

Explore how Singapore’s medtech ecosystem is transforming the Asia-Pacific region by driving innovation in healthcare and contributing significantly to economic growth. Discover how government initiatives, cutting-edge infrastructure, and strategic public-private partnerships are positioning Singapore as a global leader in medical technology, catering to both current healthcare needs and future challenges.

Qatar is set to see a significant rise in demand for advanced medical equipment, driven by rapid growth in its healthcare sector and ambitions to become a leading medical tourism destination. As part of Qatar National Vision 2030, the country is heavily investing in cutting-edge technologies, AI-driven diagnostics, and state-of-the-art facilities, making it a hub for high-quality healthcare in the Middle East

The danger of self-referential feedback loops—where AI systems endlessly recycle and distort data—is a significant concern. This phenomenon, often likened to a "fractal hall of mirrors," can lead to skewed outcomes and impaired decision-making. Vamstar AI, however, circumvents these risks through its meticulous data sourcing and processing protocols. By harnessing verified, closed industry sources, Vamstar ensures that the insights produced by its AI tools are both accurate and actionable, empowering businesses with reliable, data-driven strategies.

Discover how AI is revolutionising pharmaceutical manufacturing, from drug discovery to quality control. Learn about AI-driven tools like Vamstar's Tender AI, Pricing AI, and Value AI that streamline commercial operations, enhance market access, and empower pharmaceutical companies to stay competitive in an evolving industry. Explore the future of AI in pharma.

Leverage AI for healthcare tender management to enhance accuracy, streamline processes, and improve your bid success rates in the competitive MedTech sector.

Artificial Intelligence (AI) is emerging as a crucial enabler, particularly in the areas of tendering and Request for Proposal (RFP) management, where it is significantly enhancing efficiency and strategic decision-making.

Discover how AI and advanced analytics revolutionise tender and RFP management in the healthcare, medtech, and pharmaceutical industries. Learn how large enterprises can streamline processes, reduce cycle times, and increase win rates through AI-powered solutions. This guide provides strategic frameworks, key capabilities, and a roadmap for successful AI implementation, driving top-line growth and bottom-line savings. Transform your tender and RFP operations and gain a competitive edge with our comprehensive insights.

The pharmaceutical industry in 2024 is experiencing transformative shifts, driven by AI innovations, biosimilars, and patient-centric care. Vamstar's AI tools like Tender AI and Pricing AI streamline commercial operations, enhancing market visibility and driving growth.

2024 Medtech Landscape in 2024: Leaders and Laggards: Innovation Key for Success. Discover who's leading and lagging behind, so far.

Vamstar introduces TenderGPT, a groundbreaking AI-powered platform transforming tender and RFP management. Set to launch 7th July 2024, TenderGPT streamlines workflows, automates responses, and integrates data for swift decision-making. Key features include global tender tracking, comprehensive data integration, tender war gaming, and automatic tender document completion. This first-of-its-kind solution enhances efficiency, accuracy, and strategic planning while ensuring complete privacy. Join us at our virtual launch event for live demos and insights from industry leaders. Discover how TenderGPT can revolutionize your tender management processes. For more information and media inquiries, contact Tim F., Director of Marketing at Vamstar.

Vamstar introduces TenderGPT, a groundbreaking AI-powered platform transforming tender and RFP management. Set to launch 7th July 2024, TenderGPT streamlines workflows, automates responses, and integrates data for swift decision-making. Key features include global tender tracking, comprehensive data integration, tender war gaming, and automatic tender document completion. This first-of-its-kind solution enhances efficiency, accuracy, and strategic planning while ensuring complete privacy. Join us at our virtual launch event for live demos and insights from industry leaders. Discover how TenderGPT can revolutionize your tender management processes. For more information and media inquiries, contact Tim F., Director of Marketing at Vamstar.

MedTech companies are grappling with inflation, driven by rising costs of materials, manufacturing, and logistics. Strategic price adjustments, cost management, value enhancement, and stakeholder collaboration are essential to counter these pressures. Vamstar's advanced price prediction and analytics tools help MedTech firms make informed decisions, maintain profitability, and foster long-term growth amid challenging economic conditions.

Pharmaceutical companies are facing major headwinds due to loss of exclusivity (LOE) as product patents are set to expire, with billions in sales at stake. Vamstar's AI powered solutions can support this transition and maximise commercial outcomes.

Discover the latest trends driving a resurgence in venture capital investments in biopharma and medtech. With projections indicating a combined $50 billion in funding for 2024, these sectors are set to revolutionize healthcare innovation. Explore the factors fueling this growth, from AI advancements and regulatory support to a focus on global healthcare accessibility. As we look toward 2025, this surge in funding is laying the foundation for sustainable, patient-centered healthcare solutions worldwide.

MedTech is set for continued growth in 2024, driven by AI innovation, digital health, and evolving commercial models. Discover how the industry is overcoming rising costs and regulatory hurdles to shape the future of healthcare with cutting-edge solutions.

BRAIN Biotech AG has secured a groundbreaking EUR 128.88 million deal with Royalty Pharma, capitalising on the potential of its investigational drug deucrictibant. This transaction highlights the power of strategic partnerships in biotech growth. For companies aiming to harness similar opportunities, Vamstar's AI-driven solutions, such as Price Co-Pilot, offer advanced capabilities in price tracking and procurement, helping organizations stay competitive and optimise revenue. Learn how innovative financial strategies and AI can drive growth in the biotech sector.